U.S. Department of Commerce Invests $4.6 Million in FITCI

FITCI's [email protected] merges community, entrepreneurial spirit, and economic development in Frederick, MD

By EDA | August 30, 2022

U.S. Department of Commerce Invests $4.6 Million in American Rescue Plan Funds for Building Renovations to Support Job Growth in Frederick, MarylandWASHINGTON – Today, (4/31/22) U.S. Secretary of Commerce Gina Raimondo announced that the Department’s Economic Development Administration (EDA) is... Read more


Meridian BioGroup acquired by Pace® Life Sciences.

Expanding Regulatory, Compliance, and Validation Capabilities to the Biotechnology and Pharmaceutical Markets

By Meridian BioGroup | August 24, 2022

We are excited to announce, that Meridian BioGroup has been acquired by Pace® Life Sciences. The acquisition allows Pace® to provide regulatory and quality consulting services to support clients throughout the drug development process and improve commercial compliance in FDA-regulated... Read more


A single injection hepatitis B cure attracts international attention

Dr. Yong-Yuan Zhang presents in Paris, Seoul, and Washington DC in 2022

By April Bartel | August 19, 2022

A single injection hepatitis B cure attracts international attention Frederick, MD – HBVtech, a biopharma startup company within the Frederick Innovation Technology Center (FITCI), is garnering international attention for its work creating a single-dose injection-based hepatitis B cure. ... Read more


Mesa Science Associates Receives Grant to Study Marfan Syndrome Treatment

Development of Cobinamide as a Novel Treatment for Aortic Aneurysms of Marfan Syndrome: Phase I Pharmacokinetic Studies

By Mesa Associates, Inc. | July 15, 2022

Mesa Science Associates Inc. (MSA) received a Phase I Small Business Innovative Research Grant (SBIR) from the National Institutes of Health (NIH) entitled “Development of Cobinamide as a Novel Treatment for Aortic Aneurysms of Marfan Syndrome: Phase I Pharmacokinetic Studies.”Upon receiving... Read more


AFFORDABLE POINT OF SERVICE HEALTHCARE ACCESS COMES TO MARYLANDERS

MARYLAND BUSINESSES PARTNERSHIP TO PROVIDE TELEHEALTH PLATFORM TO MITIGATE HEALTH INEQUITY

By Ashok Kapur, Hawkeye MedTech | July 19, 2022

Columbia, MD, July 18, 2022 - Hawkeye Med Tech, Inc, a Maryland Medtech company has partnered with the Kiosk Group, Ltd,. to produce one-of-a-kind Portable TotalCare Telehealth StationTM or PTTS. PTTS is a Made in Maryland integrated telehealth tablet, blood pressure machine and pulse oximeter. PTTS... Read more


FITCI Grad BioFactura Announces Activation of a $15.9M Contract Option

Smallpox Biodefense Therapeutic, contract valued at up to $68.2 million

By Darryl Sampey, Ph.D., CEO | July 15, 2022

FREDERICK, MARYLAND, JULY 14, 2022: BioFactura today announced its second contract option activation of $15.9 million from the Biomedical Advanced Research and Development Authority (BARDA) to advance development of an antibody cocktail therapeutic for the treatment of smallpox. This funding is part... Read more


TEDCO Invests in FITCI Member, Alirtify, a Rural Maryland Pre-Seed Company

Alirtify is an intelligence-gathering platform

By Tammi Thomas, Chief Marketing & Communications Officer, TEDCO [email protected] | July 05, 2022

July 5, 2022—TEDCO, Maryland’s economic engine for technology companies (and a FITCI founding partner), announced today that its Rural Business Innovation Initiative (RBII) made a $25,000 investment in Alirtify, an intelligence-gathering platform based in Frederick, Md. “This new... Read more


Theradaptive Secures Third FDA Breakthrough Designation for Spinal Fusion

Theradaptive's technology re-grows bone

By Serena Lertora [email protected]radaptive.com | June 22, 2022

FREDERICK, Md. and BOSTON, June 22, 2022 /PRNewswire/ -- Theradaptive, a privately held biopharmaceutical company pioneering a new class of regenerative implants announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Medical Device designation for the use of OsteoAdapt... Read more


Veralox Therapeutics Announces Favorable Results of Phase 1 Studies of VLX-1005

A novel small molecule 12-LOX inhibitor, awarded Fast Track designation by US Food and Drug Administration

By | June 13, 2022

for Treatment of Heparin-Induced ThrombocytopeniaFREDERICK, Md., June 13, 2022 /PRNewswire/ -- Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat serious immuno-inflammatory diseases with significant unmet medical needs, today announced... Read more


KnowledgeNet.ai Achieves SOC 2 Type II Compliance

KnowledgeNet.ai meets the highest information security standards following an independent audit

By James Alvord | June 06, 2022

FREDERICK MD, June 7, 2022 – KnowledgeNet.ai, a leader in collaboration intelligence and knowledge sharing platform, announces the successful completion of the System and Organization Controls (SOC) 2 Type II Audit. Created by the American Institute of Certified Public Accountants (AICPA), SOC... Read more


iyotee Secures $9.35 Million In Series A Funding and Launches KnowledgeNet.ai

New AI-Driven Network Collaboration App Revolutionizes How Organizations Use Their Intellectual Capital

By James Alvord | February 11, 2022

FREDERICK MD, February 09, 2022 – KnowledgeNet.ai, a leader in knowledge intelligence, announced today that it has raised a $9.35M Series A investment round through syndicate investors. KnowledgeNet.ai goes beyond relationship intelligence to combine relationship intelligence, knowledge... Read more


FITCI Receives 2022 Grant from Rural Maryland Council

The Rural Maryland Prosperity Investment Fund Grant Will Help Build an Agricultural Technology Lab

By FITCI | October 20, 2021

(Frederick, MD) Frederick Innovative Technology Center, Inc (FITCI) was awarded Rural Maryland Council’s Rural Maryland Prosperity Investment Fund Grant for 2022 for the Ag-Tech Lab project, part of FITCI’s new Innovation Center. The funding, along with help from collaborators and partners like... Read more


FITCI earns Rural Maryland Council Outstanding Rural Economic Development Award

For Outstanding Leadership and Public Service in Advocating Policy Solutions to Greatly Benefit Rural Communities.

By April Bartel | December 07, 2021

The Frederick Innovative Technology Center, Inc. (FITCI) was recently honored for Outstanding Rural Economic Development by the Rural Maryland Council (RMC). The award was presented as part of the 2021 Rural Summit held in Annapolis on December 1 and 2. The event’s theme was Redefining... Read more


FITCI helps fellow nonprofits by “Giving BACK”

Board and staff volunteer, sharing the spirit of gratitude and generosity

By April Bartel | December 07, 2021

If November sparks gratitude and December is devoted to giving, now is a perfect time to acknowledge the good while renewing the spirit of fellowship and community. In response, team members at the Frederick Innovative Technology Center, Inc. (FITCI), a nonprofit dedicated to facilitating... Read more


Mesa Green Pharma LLC. Receives Positive Feedback from FDA’s Center for...

Pilot Study Provides Positive Results for K9MGP Treatment Active Canine Seizures

By Michael Mesa | September 27, 2021

FREDERICK, Md. September 21,2021— Mr. Michael Mesa, CEO of Mesa Green Pharma (MGP) stated that “company representatives met with FDA’s Center for Veterinary Medicine (CVM) on September 9, 2021, to discuss the company’s development program for K9MGP.” MGP is developing K9MGP as a treatment... Read more


Nanobiofab Earns $1.1M Defense Health Agency SBIR Grant for AI-powered platform

Novel nanomaterials measure pressure and volatile chemical compounds

By April Bartel | September 19, 2021

Frederick, Maryland – Tao Treasures LLC DBA Nanobiofab, a minority woman-owned nanotech startup in the Frederick Innovative Technology Center, Inc. (FITCI), is helping medical mannequins tell doctors where it hurts. The company, which creates revolutionary million-scale nanomaterial used in ... Read more


Dr. Ruoting Yang in Molecular Psychiatry on biotypes for PTSD

NanoBioFab co-founder garners industry attention

By | July 01, 2021

Geneva Scientist Dr. Ruoting Yang first-authored a manuscript published in Molecular Psychiatry on biotypes for post-traumatic stress disorder (PTSD), the first of their kind of any psychological disorder. Dr. Yang is a Computational Biologist, specializing in artificial intelligence,... Read more


THERADAPTIVE: shaping the future of regenerative medicine at military treatment...

Advanced theraputic can mean the difference between amputation and limb preservation

By The Geneva Foundation | June 30, 2021

The Geneva Foundation released a case study highlighting their work with FITCI member, Theradaptive. Theradaptive is shaping the future of regenerative medicine with a new platform to deliver therapeutics that promote targeted native tissue repair. Their lead therapeutic, AMP2, is applied... Read more


Veralox Therapeutics Appoints Michael Hanna as Chief Medical Officer

By Veralox Therapeutics | June 23, 2021

FREDERICK, MD – June 23, 2021 – Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced the appointment of Michael S. Hanna, MD, FACC, as chief... Read more


Old Line Capital Invests in CarrTech

Columbia, Maryland, June 10, 2021

By April Bartel, FITCI | June 18, 2021

Old Line Capital Partners announced today that they have made a significant investment in CarrTech LLC, to extend product development, sales, and marketing of CarrTech’s innovative filter needle. “CarrTech’s FROG device (Filter Removal of Glass) saves lives, prevents injury, and saves... Read more